$60 Million for AI-Powered Therapy Quality
Eleos Health has raised $60 million in a Series C round to scale its AI platform that helps mental health clinicians deliver better care. Unlike chatbot-based therapy apps, Eleos works alongside human therapists — not instead of them.
How It Works
The Eleos platform integrates directly into therapy sessions:
- Session analysis: AI processes session audio to identify therapeutic techniques used
- Fidelity scoring: Measures how closely treatment aligns with evidence-based protocols (CBT, DBT, MI)
- Auto-documentation: Generates clinical notes, treatment plans, and progress summaries
- Outcome tracking: Links session-level behaviors to patient outcome measures
The Problem
Mental health treatment quality is notoriously hard to measure. A therapist might say they practice CBT, but without supervision or session review, there's no way to verify technique adherence. This leads to:
- Inconsistent treatment quality across providers
- Payers unable to distinguish effective from ineffective care
- Clinician burnout from documentation overload
Why Investors Are Backing Clinical Infrastructure
The 2026 mental health investment thesis has shifted decisively. Investors are no longer funding meditation apps or general wellness platforms. The money is flowing to companies that:
- Embed into clinical workflows rather than compete with them
- Align with payer incentives through measurable outcomes
- Reduce clinician burden rather than replace clinicians
What to Watch
Eleos is positioning itself as the quality measurement layer for behavioral health — the same role that laboratory testing plays in physical medicine. If they succeed, every mental health session could come with objective quality metrics.
